1. Home
  2. ALEX vs PCRX Comparison

ALEX vs PCRX Comparison

Compare ALEX & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALEX
  • PCRX
  • Stock Information
  • Founded
  • ALEX 1870
  • PCRX 2006
  • Country
  • ALEX United States
  • PCRX United States
  • Employees
  • ALEX N/A
  • PCRX N/A
  • Industry
  • ALEX Real Estate Investment Trusts
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALEX Real Estate
  • PCRX Health Care
  • Exchange
  • ALEX Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • ALEX 1.3B
  • PCRX 1.1B
  • IPO Year
  • ALEX N/A
  • PCRX 2011
  • Fundamental
  • Price
  • ALEX $16.83
  • PCRX $24.65
  • Analyst Decision
  • ALEX Buy
  • PCRX Buy
  • Analyst Count
  • ALEX 3
  • PCRX 9
  • Target Price
  • ALEX $23.00
  • PCRX $30.11
  • AVG Volume (30 Days)
  • ALEX 634.9K
  • PCRX 1.2M
  • Earning Date
  • ALEX 04-24-2025
  • PCRX 05-06-2025
  • Dividend Yield
  • ALEX 5.34%
  • PCRX N/A
  • EPS Growth
  • ALEX 103.57
  • PCRX N/A
  • EPS
  • ALEX 0.83
  • PCRX N/A
  • Revenue
  • ALEX $241,197,000.00
  • PCRX $700,966,000.00
  • Revenue This Year
  • ALEX N/A
  • PCRX $9.48
  • Revenue Next Year
  • ALEX $2.81
  • PCRX $11.31
  • P/E Ratio
  • ALEX $19.13
  • PCRX N/A
  • Revenue Growth
  • ALEX 14.47
  • PCRX 3.85
  • 52 Week Low
  • ALEX $15.53
  • PCRX $11.16
  • 52 Week High
  • ALEX $20.30
  • PCRX $31.67
  • Technical
  • Relative Strength Index (RSI)
  • ALEX 47.64
  • PCRX 51.22
  • Support Level
  • ALEX $15.70
  • PCRX $24.10
  • Resistance Level
  • ALEX $16.69
  • PCRX $25.35
  • Average True Range (ATR)
  • ALEX 0.52
  • PCRX 1.49
  • MACD
  • ALEX 0.03
  • PCRX 0.01
  • Stochastic Oscillator
  • ALEX 58.55
  • PCRX 48.89

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: